Annual industry position survey seeking CEOs' views
AusBiotech calls on leaders of biotechnology companies (CEOs and MDs) to respond to the annual Biotechnology Industry Position Survey 2015, enabling them to contribute to the annual snapshot and build the advocacy platform for the year to come.
AusBiotech conducts the confidential survey early each year to formally seek opinions and information from the leaders of the industry it represents, in order to get a comprehensive view of the Australian biotechnology sector based on industry experience, knowledge, key metrics and political insight.
While input on public policy is a year-round, ongoing and core part of AusBiotech’s work, the survey informs efforts, and the industry’s contribution and support makes those efforts far more powerful.
The results help build metrics about the significance of the industry and its perspectives, and enable AusBiotech to make strong statements about the magnitude of issues, trends and company practices.
The collated results also appear in a printed report that is widely used as a source of industry views and information, as well as giving valuable ballast to AusBiotech’s advocacy efforts.
AusBiotech and survey sponsor Grant Thornton will be conducting three facilitated focus groups (NSW, Vic and Qld) for CEOs, MDs or their C-suite delegate in April to discuss the ‘Government Policy’ section of the survey in more detail.
The survey has been posted and emailed to biotechnology company leaders and responses are invited now. It is available until 27 February at https://www.surveymonkey.com/r/CEOAusBiotech15.
If you have any questions about the survey, or the focus groups and your company’s participation, please contact Lorraine Chiroiu (AusBiotech’s communications manager) at lchiroiu@ausbiotech.org or (03) 9828 1400
mRNA successfully delivered through blood–brain barrier
Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic...
Biological computer could revolutionise medical sciences
The CL1 is a commercial biological computer which fuses lab-cultivated neurons from human stem...
Genetic risk of schizophrenia impacts men and women differently
Men tend to present different clinical symptoms from women, poorer premorbid functioning and...